UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)

Q: What does CUSIP M96088105 represent in this 13F holders report?

CUSIP M96088105 is the security identifier for URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share used to aggregate holder disclosures.

Q: How many institutions held URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share in Q3 2025?

159 institutional investors reported URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share for Q3 2025. Use the holders table for investor-level position and value details.

CUSIP: M96088105

Q3 2025 13F Holders as of 30 Sep 2025

Security type / class: Equity / Ordinary Shares, par value NIS 0.01 per share
Total 13F shares: 43,904,765
Total 13F value: $877,180,169
Share change: +3,965,252
Put/Call ratio: 27%
SEC-reported price per share: $19.95
Number of holders: 159
Value change: +$94,297,658
Number of buys: 80
Number of sells: 67
Shares outstanding: 48,684,257

Security key

M96088105

Report period

Q3 2025

Institutions

159

Top holders

URGN full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2025 Previous quarter: Q2 2025 UroGen Pharma Ltd. SEC filings UroGen Pharma Ltd. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP M96088105

Newer quarter: Q4 2025 Previous quarter: Q2 2025

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of URGN - UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

MORGAN STANLEY

Disclosed value leader

RTW INVESTMENTS, LP

Comparable rows

15/15

Latest evidence

30 Jun 2025

13D/G 13F Lead comparable stake: 5.4% 13D/G row: MORGAN STANLEY Showing 1-6 of 15 holder rows.

Quick read

MORGAN STANLEY leads the comparable SEC ownership view at 5.4%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens MORGAN STANLEY's linked filing trail.

Comparable ownership Top 5

MORGAN STANLEY 5.4%

MENORA MIVTACHIM HOLDINGS LTD. 5%

Soleus Capital Master Fund, L.P. 4.7%

Adage Capital Management, L.P. 2.8%

Monograph Capital Holdings Adviso... 1.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
MORGAN STANLEY	13D/G 13F Company 13D/G 13F	5.4%	$35,433,378 2,488,299 shares	+$24,712,637	30 Jun 2025
MENORA MIVTACHIM HOLDINGS LTD.	13D/G 13F Company 13D/G 13F	5%	$24,780,614 2,303,031 shares	$0	11 Mar 2025
Soleus Capital Master Fund, L.P.	13D/G 13D/G	4.7%	$31,114,400 2,185,000 shares	-$1,993,600	30 Jun 2025
Adage Capital Management, L.P.	13D/G 13D/G	2.8%	$13,740,520 1,277,000 shares	-$17,765,685	31 Mar 2025
Monograph Capital Holdings Advisors, LLC	13D/G Monograph Capital Partners I, L.P. 13D/G	1.8%	$8,503,556 838,615 shares	$0	05 Jun 2025
RTW INVESTMENTS, LP	13F Company 13F	9.3%	$62,251,362 4,543,895 shares	—	30 Jun 2025

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

159

43,904,765

Rows available

159

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders

149

Q3 2025 holders

159

Holder diff

Investor	Q2 2025 Shares	Q3 2025 Shares	Share Diff	Share Chg %	Q2 2025 value	Q3 2025 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend